March 18, 2015

Statin Therapy and Risk of Fracture: Results From the JUPITER Randomized Clinical Trial

.   .   

This analysis of the JUPITER trialled showed that rosuvastatin did not reduce fracture risk in the enrolled patients with elevated hs-CRP levels.  Furthermore, higher baseline hs-CRP levels were nor associated with an increased risk of fractures in both groups.

Related Articles:

Clinical Nephrology, Clinical Trial Results

Comments are closed.